JP2017538822A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538822A5 JP2017538822A5 JP2017531176A JP2017531176A JP2017538822A5 JP 2017538822 A5 JP2017538822 A5 JP 2017538822A5 JP 2017531176 A JP2017531176 A JP 2017531176A JP 2017531176 A JP2017531176 A JP 2017531176A JP 2017538822 A5 JP2017538822 A5 JP 2017538822A5
- Authority
- JP
- Japan
- Prior art keywords
- amine polymer
- preform
- process according
- polymer
- swelling agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims description 187
- 150000001412 amines Chemical class 0.000 claims description 166
- 238000000034 method Methods 0.000 claims description 121
- 230000008961 swelling Effects 0.000 claims description 76
- 239000003795 chemical substances by application Substances 0.000 claims description 66
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 57
- 239000011541 reaction mixture Substances 0.000 claims description 50
- 239000002904 solvent Substances 0.000 claims description 28
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims description 22
- 229910019142 PO4 Inorganic materials 0.000 claims description 18
- 229920006037 cross link polymer Polymers 0.000 claims description 17
- 238000004132 cross linking Methods 0.000 claims description 17
- 239000003431 cross linking reagent Substances 0.000 claims description 17
- 239000010452 phosphate Substances 0.000 claims description 17
- 239000000872 buffer Substances 0.000 claims description 16
- 239000006185 dispersion Substances 0.000 claims description 16
- 210000000813 small intestine Anatomy 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical group NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims description 14
- 239000005977 Ethylene Chemical group 0.000 claims description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 13
- 230000003247 decreasing effect Effects 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 12
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical group CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 11
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical class C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 229940085991 phosphate ion Drugs 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 238000003556 assay Methods 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 230000002496 gastric effect Effects 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 4
- 230000002745 absorbent Effects 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 230000000717 retained effect Effects 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims description 3
- KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 claims description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 2
- 150000001266 acyl halides Chemical class 0.000 claims description 2
- 150000001299 aldehydes Chemical group 0.000 claims description 2
- 150000001350 alkyl halides Chemical group 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 150000002118 epoxides Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- NONOKGVFTBWRLD-UHFFFAOYSA-N isocyanatosulfanylimino(oxo)methane Chemical compound O=C=NSN=C=O NONOKGVFTBWRLD-UHFFFAOYSA-N 0.000 claims description 2
- 150000002576 ketones Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 235000021317 phosphate Nutrition 0.000 claims 3
- -1 diallyl propyl diamine Chemical class 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- GJKBBHAIYHTKRL-UHFFFAOYSA-N 1,1-dichloroethane;heptane Chemical compound CC(Cl)Cl.CCCCCCC GJKBBHAIYHTKRL-UHFFFAOYSA-N 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical group [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020104945A JP6921276B2 (ja) | 2014-12-10 | 2020-06-18 | 経口投与用プロトン結合ポリマー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462090287P | 2014-12-10 | 2014-12-10 | |
| US62/090,287 | 2014-12-10 | ||
| PCT/US2015/065041 WO2016094685A1 (en) | 2014-12-10 | 2015-12-10 | Proton-binding polymers for oral administration |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020104945A Division JP6921276B2 (ja) | 2014-12-10 | 2020-06-18 | 経口投与用プロトン結合ポリマー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538822A JP2017538822A (ja) | 2017-12-28 |
| JP2017538822A5 true JP2017538822A5 (cg-RX-API-DMAC7.html) | 2019-01-24 |
| JP6903576B2 JP6903576B2 (ja) | 2021-07-14 |
Family
ID=55080167
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017531176A Active JP6903576B2 (ja) | 2014-12-10 | 2015-12-10 | 経口投与用プロトン結合ポリマー |
| JP2020104945A Active JP6921276B2 (ja) | 2014-12-10 | 2020-06-18 | 経口投与用プロトン結合ポリマー |
| JP2021122260A Active JP7258087B2 (ja) | 2014-12-10 | 2021-07-27 | 経口投与用プロトン結合ポリマー |
| JP2023060573A Active JP7536343B2 (ja) | 2014-12-10 | 2023-04-04 | 経口投与用プロトン結合ポリマー |
| JP2024124273A Pending JP2024164031A (ja) | 2014-12-10 | 2024-07-31 | 経口投与用プロトン結合ポリマー |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020104945A Active JP6921276B2 (ja) | 2014-12-10 | 2020-06-18 | 経口投与用プロトン結合ポリマー |
| JP2021122260A Active JP7258087B2 (ja) | 2014-12-10 | 2021-07-27 | 経口投与用プロトン結合ポリマー |
| JP2023060573A Active JP7536343B2 (ja) | 2014-12-10 | 2023-04-04 | 経口投与用プロトン結合ポリマー |
| JP2024124273A Pending JP2024164031A (ja) | 2014-12-10 | 2024-07-31 | 経口投与用プロトン結合ポリマー |
Country Status (26)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102633597B1 (ko) | 2013-06-05 | 2024-02-06 | 트리시다, 인크. | 경구 투여를 위한 양성자-결합 중합체 |
| IL322207A (en) | 2014-12-10 | 2025-09-01 | Tricida Inc | Proton-binding polymers for oral administration |
| IL262660B2 (en) * | 2016-05-06 | 2024-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| JP6792640B2 (ja) | 2016-12-28 | 2020-11-25 | 富士フイルム株式会社 | 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法 |
| US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
| EP3698799B1 (en) | 2017-10-16 | 2022-01-26 | FUJIFILM Corporation | Hyperphosphatemia treatment agent |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| CA3080143A1 (en) * | 2017-11-03 | 2019-05-09 | Tricida, Inc. | Method of treating acid-base disorders |
| MA51628A (fr) | 2018-06-04 | 2021-03-17 | Tricida Inc | Méthode de traitement de troubles de l'équilibre acido-basique |
| WO2019236124A1 (en) * | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
| BR112023017628A2 (pt) * | 2021-03-01 | 2023-12-05 | Tricida Inc | Composições farmacêuticas de polímero de poli(alilamina) reticulado |
| SI4053179T1 (sl) | 2021-03-01 | 2026-01-30 | Renosis, Inc. | Farmacevtski sestavki iz premreženega poli(alilaminskega) polimera |
Family Cites Families (125)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−2−ベンゾフランカルボン酸誘導体 |
| US6444221B1 (en) | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
| US20050090553A1 (en) | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| US5556619A (en) * | 1992-08-20 | 1996-09-17 | The Du Pont Merck Pharmaceutical Company | Crosslinked polymeric ammonium salts |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5648355A (en) | 1994-02-09 | 1997-07-15 | Kos Pharmaceutical, Inc. | Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| TW474813B (en) * | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
| EP0786993B1 (en) | 1994-10-17 | 2002-06-05 | Peter W. Stacpoole | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and their use in the treatment of metabolic and cardiovascular disorders |
| US20020006899A1 (en) | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
| US5753706A (en) | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
| JP3952223B2 (ja) * | 1997-05-28 | 2007-08-01 | 日東紡績株式会社 | アリルアミン重合体 |
| AUPO758297A0 (en) | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
| US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
| ES2243016T3 (es) * | 1997-12-17 | 2005-11-16 | MERCK & CO., INC. | Antagonistas de receptores de integrinas. |
| WO1999040990A1 (en) | 1998-02-17 | 1999-08-19 | University Of Maryland | Anion binding polymers and the use thereof |
| US6485703B1 (en) | 1998-07-31 | 2002-11-26 | The Texas A&M University System | Compositions and methods for analyte detection |
| US6271264B1 (en) | 1998-12-01 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| GB9927088D0 (en) | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
| US20040059065A1 (en) | 2000-03-09 | 2004-03-25 | Takeshi Goto | Crosslinked anion-exchange resin or salt thereof |
| WO2001066607A1 (en) | 2000-03-09 | 2001-09-13 | Hisamitsu Pharmaceutical Co., Inc. | Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same |
| AU2001241095A1 (en) | 2000-03-13 | 2001-09-24 | Hisamitsu Pharmaceutical Co. Inc. | Preventives and/or remedies for hyperphosphatemia |
| JP2002028737A (ja) | 2000-07-07 | 2002-01-29 | Fujitsu Ltd | プレス打ち抜き加工方法及びプレス打ち抜き加工装置 |
| BR0209020A (pt) | 2001-04-18 | 2004-08-10 | Genzyme Corp | Composição farmacêutica de polialilamina |
| CA2444347A1 (en) | 2001-04-18 | 2002-10-31 | Genzyme Corporation | Method for treating gout and binding uric acid |
| JP2005519949A (ja) | 2002-03-11 | 2005-07-07 | ノバルティス アクチエンゲゼルシャフト | ナテグリニドの塩 |
| BR0305717A (pt) * | 2002-08-02 | 2004-09-28 | Tibotec Pharm Ltd | Inibidores da protease do hiv 2-amino-benzotiazol sulfonamida de amplo espectro |
| EP1597276A4 (en) | 2003-02-10 | 2006-11-29 | Autogen Res Pty Ltd | Therapeutic molecules |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| WO2004113872A2 (en) * | 2003-06-24 | 2004-12-29 | The Trustees Of Columbia University In The City Of New York | Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces |
| US7459502B2 (en) | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US7449605B2 (en) | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7385012B2 (en) | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
| US7608674B2 (en) | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
| CA2551528A1 (en) | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
| US20080248012A1 (en) | 2004-01-29 | 2008-10-09 | Keio University | Erythrocyte Function Modifying Substance |
| US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
| US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
| US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
| KR101153035B1 (ko) | 2004-03-30 | 2012-06-11 | 리립사, 인크. | 이온 결합 조성물 |
| US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
| US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
| US8399025B2 (en) | 2004-06-04 | 2013-03-19 | Board Of Regents, The University Of Texas System | Polyamine modified particles |
| PL1771191T3 (pl) | 2004-07-19 | 2014-08-29 | Nutricia Nv | Preparat do zastosowania asparaginianu i witaminy B12 lub biotyny do regulowania poziomu ciał ketonowych |
| DE102004035808A1 (de) | 2004-07-21 | 2006-03-16 | Kasch, Helmut, Dr. | Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen |
| US8569277B2 (en) | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
| US20070293429A1 (en) | 2004-10-08 | 2007-12-20 | Therapei Pharmaceuticals, Inc. | Vasoactive Intestinal Polypeptide Compositions |
| US20080214440A1 (en) | 2004-10-08 | 2008-09-04 | Forbes Medi-Tech (Research), Inc. | Vasoactive intestinal polypeptide compositions |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
| EP1898922A4 (en) | 2005-07-04 | 2012-03-14 | Ramu Krishnan | MEDICINE OR IMPROVED PHARMACEUTICAL COMPOUNDS AND PREPARATION THEREOF |
| NZ566743A (en) | 2005-08-18 | 2010-07-30 | Globoasia Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
| JP2009510126A (ja) | 2005-09-30 | 2009-03-12 | レリプサ, インコーポレイテッド | 哺乳類の胃腸管からカリウムイオンを選択的に除去するための方法および組成物 |
| WO2007038801A2 (en) | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof |
| CN101321519A (zh) | 2005-09-30 | 2008-12-10 | 伊立普萨公司 | 制备含有交联壳的核-壳型复合物的方法及其得到的核-壳型复合物 |
| EP1946763B1 (en) | 2005-11-08 | 2013-08-21 | Ajinomoto Co., Inc. | Promoter for recovery from anesthesia |
| CA2626734A1 (en) * | 2005-11-08 | 2007-05-18 | Genzyme Corporation | Magnesium-containing polymers for the treatment of hyperphosphatemia |
| ITMI20052461A1 (it) | 2005-12-22 | 2007-06-23 | Univ Degli Studi Milano | Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive |
| RU2008136081A (ru) * | 2006-02-14 | 2010-03-20 | Тева Фармасьютикл Индастриес Лтд. (Il) | Фармацевтические составы с алифатическими аминными полимерами и способы их производства |
| JP2009536246A (ja) | 2006-05-05 | 2009-10-08 | ゲンズイメ コーポレーション | ホスフェート捕捉剤としてのアミン縮合重合体 |
| US20100135950A1 (en) | 2006-07-05 | 2010-06-03 | Genzyme Corporation | Iron(II)-Containing Treatments for Hyperphosphatemia |
| US20100124542A1 (en) | 2006-07-18 | 2010-05-20 | Genzyme Corporation | Amine dendrimers |
| AU2007281433A1 (en) | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Compositions for intranasal delivery of human insulin and uses thereof |
| WO2008027551A2 (en) | 2006-09-01 | 2008-03-06 | Genzyme Corporation | Dendrimer compositions |
| US7964182B2 (en) | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
| EP2441779A1 (en) | 2006-09-01 | 2012-04-18 | USV Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
| US7868045B2 (en) | 2006-09-06 | 2011-01-11 | Sucampo Ag | Method for promoting gastrointestinal bicarbonate secretion |
| BRPI0717545A2 (pt) | 2006-09-29 | 2013-10-22 | Gezyme Corp | Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida |
| JP2010513271A (ja) | 2006-12-14 | 2010-04-30 | ゲンズイメ コーポレーション | アミド−アミンポリマー組成物 |
| US20100129309A1 (en) | 2007-02-23 | 2010-05-27 | Dhal Pradeep K | Amine polymer compositions |
| US20080207766A1 (en) | 2007-02-27 | 2008-08-28 | Agi Therapeutics Research Ltd. | Methods and compositions for treating at least one upper gastrointestinal symptom |
| US20100196305A1 (en) | 2007-03-08 | 2010-08-05 | Dhal Pradeep K | Sulfone polymer compositions |
| TWI445540B (zh) | 2007-04-20 | 2014-07-21 | Ajinomoto Kk | 抗低體溫組成物 |
| EP2152277A1 (en) | 2007-04-27 | 2010-02-17 | Genzyme Corporation | Amido-amine dendrimer compositions |
| WO2009005838A2 (en) | 2007-07-02 | 2009-01-08 | Cognate3 Llc | Process for the preparation of a non-corrosive base solution and methods of using same |
| JPWO2009008480A1 (ja) | 2007-07-11 | 2010-09-09 | 東レ株式会社 | 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途 |
| EP2016947A1 (en) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
| WO2009023544A2 (en) | 2007-08-10 | 2009-02-19 | Ilypsa, Inc. | Dosage unit anion-exchange polymer pharmaceutical compositions |
| US20090125433A1 (en) * | 2007-11-13 | 2009-05-14 | Franck Rene Mikulecz | Best pre-match routing (of foreign exchange orders) |
| US20090156647A1 (en) | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
| PA8807201A1 (es) | 2007-12-14 | 2009-07-23 | Genzyme Corp | Composiciones farmaceuticas |
| JP2011506449A (ja) | 2007-12-14 | 2011-03-03 | ジェンザイム コーポレーション | コーティング医薬組成物 |
| WO2009097127A1 (en) | 2008-01-31 | 2009-08-06 | Genzyme Corporation | Pharmaceutical compositions |
| JP2009179724A (ja) * | 2008-01-31 | 2009-08-13 | Toray Ind Inc | 架橋ポリビニルアミン又はその酸付加塩、及びその医薬用途 |
| US20100035992A1 (en) | 2008-03-11 | 2010-02-11 | Rajiv Bhushan | Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies |
| BRPI0911041A2 (pt) * | 2008-04-08 | 2016-07-05 | Usv Ltd | processo para a preparação de sal de polímero de amina |
| EP2265238B1 (en) | 2008-04-11 | 2012-01-11 | GP Investimenti S.r.l. | Handpiece for ultrasound treatments of human tissue |
| WO2009154747A1 (en) | 2008-06-20 | 2009-12-23 | Genzyme Corporation | Pharmaceutical compositions |
| DE102008030046A1 (de) | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
| US20100008988A1 (en) | 2008-07-14 | 2010-01-14 | Glenmark Generics, Ltd. | Tablet compositions of amine polymers |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| WO2010022381A1 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
| WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
| BRPI0920515B1 (pt) | 2008-09-25 | 2018-03-20 | Vive Nano, Inc. | Composição compreendendo nanopartícula de polímero e composto ativo agrícola |
| US20110268666A1 (en) | 2008-09-29 | 2011-11-03 | Yissum Research Development Company of the Research University of Jerusalem, Ltd. | Novel gastroretentive delivery system |
| WO2010059384A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists |
| US20100166861A1 (en) | 2008-12-29 | 2010-07-01 | Kelly Noel Lynch | Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |
| CN103819403B (zh) * | 2008-12-31 | 2017-01-04 | 阿德利克斯公司 | 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法 |
| US20110081413A1 (en) | 2009-01-22 | 2011-04-07 | Ashok Omray | Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| CA2777682C (en) | 2009-10-13 | 2015-02-24 | The Regents Of The University Of Michigan | Dendrimer compositions and methods of synthesis |
| DK2490675T3 (en) | 2009-10-22 | 2019-04-29 | Synthon Bv | Pharmaceutical compositions with sevelamer |
| KR20120103689A (ko) | 2009-12-07 | 2012-09-19 | 아이언우드 파마슈티컬스, 인코포레이티드 | 위장 장애의 치료 |
| BR112012021448A2 (pt) | 2010-02-24 | 2016-05-31 | Relypsa Inc | polímero de amina, método para tratar doença, método de remoção de sais biliares de um indivíduo animal, método para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de amina. |
| ES2549513T3 (es) * | 2010-02-24 | 2015-10-28 | Relypsa, Inc. | Polivinilamina, polialilamina y polietilenimina reticuladas para uso como secuestradores de ácidos biliares |
| IT1406068B1 (it) | 2010-07-22 | 2014-02-06 | Medestea Int Spa | Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| KR101238210B1 (ko) | 2011-06-30 | 2013-03-04 | 엘지전자 주식회사 | 이동 단말기 |
| US20130137772A1 (en) | 2011-11-29 | 2013-05-30 | Raymond J. Bergeron | Hydroxypolyamine salts |
| SG11201408521WA (en) | 2012-06-21 | 2015-01-29 | Keryx Biopharmaceuticals Inc | Use of ferric citrate in the treatment of chronic kidney disease patients |
| ES3059226T3 (en) | 2012-10-08 | 2026-03-19 | Vifor Int Ltd | Potassium-binding agents for treating hypertension and hyperkalemia |
| KR102633597B1 (ko) | 2013-06-05 | 2024-02-06 | 트리시다, 인크. | 경구 투여를 위한 양성자-결합 중합체 |
| CN105873583A (zh) | 2013-11-04 | 2016-08-17 | 凯克斯生物制药公司 | 用于降低慢性肾病患者的心力衰竭的枸橼酸铁 |
| IL322207A (en) | 2014-12-10 | 2025-09-01 | Tricida Inc | Proton-binding polymers for oral administration |
| IL262660B2 (en) | 2016-05-06 | 2024-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
| CA3080143A1 (en) | 2017-11-03 | 2019-05-09 | Tricida, Inc. | Method of treating acid-base disorders |
| IL319146A (en) | 2017-11-03 | 2025-04-01 | Tricida Inc | Compositions for and method of treating acid-base disorders |
| WO2019236124A1 (en) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
| WO2019236639A1 (en) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
| MA51628A (fr) | 2018-06-04 | 2021-03-17 | Tricida Inc | Méthode de traitement de troubles de l'équilibre acido-basique |
| US20200306209A1 (en) | 2019-03-27 | 2020-10-01 | Tricida, Inc. | Method of treating acid-base disorders |
-
2015
- 2015-12-10 IL IL322207A patent/IL322207A/en unknown
- 2015-12-10 ES ES15823049T patent/ES2787218T3/es active Active
- 2015-12-10 RU RU2020102937A patent/RU2020102937A/ru unknown
- 2015-12-10 MX MX2017007497A patent/MX377154B/es active IP Right Grant
- 2015-12-10 RS RS20200504A patent/RS60208B1/sr unknown
- 2015-12-10 EP EP19191396.1A patent/EP3593808B1/en active Active
- 2015-12-10 HU HUE19191396A patent/HUE052736T2/hu unknown
- 2015-12-10 EP EP26154370.6A patent/EP4755931A3/en active Pending
- 2015-12-10 SI SI201531167T patent/SI3229816T1/sl unknown
- 2015-12-10 US US15/533,705 patent/US11311571B2/en active Active
- 2015-12-10 EP EP20154562.1A patent/EP3718551B1/en active Active
- 2015-12-10 HU HUE15823049A patent/HUE049057T2/hu unknown
- 2015-12-10 ES ES19191396T patent/ES2857177T3/es active Active
- 2015-12-10 MD MDE20200240T patent/MD3593808T2/ro unknown
- 2015-12-10 HR HRP20200689TT patent/HRP20200689T1/hr unknown
- 2015-12-10 SM SM20200700T patent/SMT202000700T1/it unknown
- 2015-12-10 KR KR1020247000875A patent/KR102920551B1/ko active Active
- 2015-12-10 MA MA48486A patent/MA48486B1/fr unknown
- 2015-12-10 MA MA053106A patent/MA53106A/fr unknown
- 2015-12-10 DK DK15823049.0T patent/DK3229816T3/da active
- 2015-12-10 PL PL15823049T patent/PL3229816T3/pl unknown
- 2015-12-10 LT LTEP19191396.1T patent/LT3593808T/lt unknown
- 2015-12-10 EP EP15823049.0A patent/EP3229816B1/en active Active
- 2015-12-10 CA CA3205149A patent/CA3205149C/en active Active
- 2015-12-10 CA CA3164664A patent/CA3164664C/en active Active
- 2015-12-10 SM SM20200225T patent/SMT202000225T1/it unknown
- 2015-12-10 MD MDE20170179T patent/MD3229816T2/ro unknown
- 2015-12-10 BR BR112017011838-6A patent/BR112017011838B1/pt active IP Right Grant
- 2015-12-10 LT LTEP15823049.0T patent/LT3229816T/lt unknown
- 2015-12-10 CN CN201580075741.9A patent/CN107428955B/zh active Active
- 2015-12-10 JP JP2017531176A patent/JP6903576B2/ja active Active
- 2015-12-10 MA MA41150A patent/MA41150B1/fr unknown
- 2015-12-10 KR KR1020177018413A patent/KR102625115B1/ko active Active
- 2015-12-10 KR KR1020267002683A patent/KR20260017508A/ko active Pending
- 2015-12-10 BR BR122021001914-2A patent/BR122021001914B1/pt active IP Right Grant
- 2015-12-10 PL PL19191396T patent/PL3593808T3/pl unknown
- 2015-12-10 WO PCT/US2015/065041 patent/WO2016094685A1/en not_active Ceased
- 2015-12-10 MX MX2019014711A patent/MX382077B/es unknown
- 2015-12-10 AU AU2015360413A patent/AU2015360413B2/en active Active
- 2015-12-10 ME MEP-2020-85A patent/ME03783B/me unknown
- 2015-12-10 RU RU2017124157A patent/RU2713416C2/ru active
- 2015-12-10 CA CA2969238A patent/CA2969238C/en active Active
- 2015-12-10 IL IL290729A patent/IL290729B2/en unknown
- 2015-12-10 DK DK19191396.1T patent/DK3593808T3/da active
- 2015-12-10 PT PT191913961T patent/PT3593808T/pt unknown
- 2015-12-10 CA CA3280357A patent/CA3280357A1/en active Pending
- 2015-12-10 PT PT158230490T patent/PT3229816T/pt unknown
- 2015-12-10 RS RS20210136A patent/RS61409B1/sr unknown
- 2015-12-10 CN CN202111132616.0A patent/CN113855703B/zh active Active
- 2015-12-10 SI SI201531470T patent/SI3593808T1/sl unknown
-
2017
- 2017-05-22 IL IL252439A patent/IL252439B/en active IP Right Grant
- 2017-06-08 MX MX2021004558A patent/MX2021004558A/es unknown
-
2020
- 2020-04-30 CY CY20201100400T patent/CY1122928T1/el unknown
- 2020-06-18 JP JP2020104945A patent/JP6921276B2/ja active Active
- 2020-10-13 IL IL278034A patent/IL278034B/en unknown
-
2021
- 2021-02-05 HR HRP20210204TT patent/HRP20210204T1/hr unknown
- 2021-02-19 CY CY20211100141T patent/CY1124073T1/el unknown
- 2021-07-27 JP JP2021122260A patent/JP7258087B2/ja active Active
- 2021-10-06 AU AU2021245144A patent/AU2021245144B2/en active Active
-
2022
- 2022-04-19 US US17/724,105 patent/US11738041B2/en active Active
-
2023
- 2023-04-04 JP JP2023060573A patent/JP7536343B2/ja active Active
- 2023-08-28 US US18/238,665 patent/US20230405043A1/en active Pending
-
2024
- 2024-07-31 JP JP2024124273A patent/JP2024164031A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017124157A (ru) | Протон-связывающие полимеры для перорального введения | |
| CN106536516B (zh) | 用于制备吡啶化合物的方法 | |
| CN100548978C (zh) | 作为m3毒蕈碱性受体拮抗剂的吡咯烷衍生物 | |
| BRPI0717545A2 (pt) | Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida | |
| WO2003086316A2 (en) | Degradable crosslinkers, and degradable crosslinked hydrogels comprising them | |
| TWI786553B (zh) | 二唑衍生物化合物及包含其的醫藥組合物 | |
| DE112011100657T5 (de) | Amin-polymere zur verwendung als gallensäuresequestriermittel | |
| JPH11500161A (ja) | 高分子化合物 | |
| JPH06505265A (ja) | ヒスタミンh↓3受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体 | |
| JPH0253453B2 (cg-RX-API-DMAC7.html) | ||
| JP5430812B2 (ja) | 脱除剤樹脂及びその使用方法 | |
| JP2022037143A (ja) | 終末糖化産物(age)前駆体の捕捉剤 | |
| CN116251226A (zh) | 一种不透射线显影栓塞微球及其制备方法 | |
| WO2009154747A1 (en) | Pharmaceutical compositions | |
| JP2009507019A (ja) | リン酸塩を除去する方法およびそれに使用される重合体 | |
| US9475891B2 (en) | Process for the preparation of colesevelam hydrochloride | |
| WO2014122586A1 (en) | Oral pharmaceutical composition of aliphatic amine polymer or salts thereof | |
| JP2019518023A (ja) | アミド結合を切断するための方法 | |
| TW202434299A (zh) | 製造水凝膠微球之方法 | |
| WO2024199096A1 (zh) | 一种抗凝逆转剂及其制备方法和应用 | |
| KR101853260B1 (ko) | 세벨라머 카보네이트의 제조방법 | |
| CZ2003736A3 (cs) | Způsob promývání k čištění polymerů obsahujících atom dusíku nebo aminoskupinu, amoniovou nebo spirobicyklickou amoniovou skupinu | |
| CN106632041B (zh) | 一种酒石酸左洛啡烷的制备方法 | |
| EP3727340B1 (en) | Pharmaceutical composition containing crosslinked ion exchange resin | |
| CN117285511B (zh) | 吲哚杂化的喹诺酮类化合物及其制备方法和应用 |